The Novel UDP Glycosyltransferase 3A2: Cloning, Catalytic Properties, and Tissue Distribution

Determination of mRNA Expression of Human UDP-Glucuronosyltransferases and Application for Localization in Various Human Tissues by Real-Time Reverse Transcriptase-Polymerase Chain Reaction

Shuji Ohno, Shizuo Nakajin · Drug Metabolism and Disposition · 2008 · 425 citations

Life Sciences, Biochemistry, Molecular Biology +13

HUMAN UDP-GLUCURONOSYLTRANSFERASES: ISOFORM SELECTIVITY AND KINETICS OF 4-METHYLUMBELLIFERONE AND 1-NAPHTHOL GLUCURONIDATION, EFFECTS OF ORGANIC SOLVENTS, AND INHIBITION BY DICLOFENAC AND PROBENECID

Verawan Uchaipichat, Peter I. Mackenzie, Xiao-Hui Guo et al. · Drug Metabolism and Disposition · 2004 · 334 citations

Life Sciences, Biochemistry, Pharmacology +14

A Novel Mechanism for the Inhibition of Hyaluronan Biosynthesis by 4-Methylumbelliferone

Ikuko Kakizaki, Kaoru Kojima, Keiichi Takagaki et al. · Journal of Biological Chemistry · 2004 · 290 citations · Full text

Life Sciences, Biochemistry, Pharmacology +15

Development of a Bicistronic Vector Driven by the Human Polypeptide Chain Elongation Factor 1α Promoter for Creation of Stable Mammalian Cell Lines That Express Very High Levels of Recombinant Proteins

Stephen M. Hobbs, Sarawut Jitrapakdee, John C. Wallace · Biochemical and Biophysical Research Communications · 1998 · 258 citations

Life Sciences, Biotechnology, Molecular Biology +17

The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and<i>in vitro–in vivo</i>extrapolation of drug clearance and drug-drug interaction potential

John O. Miners, Peter I. Mackenzie, Kathleen Knights · Drug Metabolism Reviews · 2009 · 226 citations

Pharmacy, Pharmacokinetics, Pharmacology +17